from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1462/-

LFCtreatmentdescriptionclass of inhibitor

-1.314

Amikacinug/mL Amikacintranslation

-1.607

Cap5-10ug/mL Capreomycintranslation

-2.117

Rox10-50 ug/mL Roxithromycintranslation

0.908

SM2-5 ug/mL Streptomycintranslation

-2.356

Tet5-10 ug/mL Tetracyclinetranslation

-1.333

Rif0.2-5ug/mL Rifampicintranscription

-0.576

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.000

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.112

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.413

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.070

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.409

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.130

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.147

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.487

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.018

Nigericin50 uM Nigericinrespiration

1.969

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.328

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.000

menadione6-10 ug/mL Menadionerespiration

1.988

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.185

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.754

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.000

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.216

NRP_1Non-replicating persistence stage 1dosRassociated

-0.027

Amp0.2mg/mL AmpicillincellWall

-0.250

Cephalexin20-100 ug/mL CephalexincellWall

-0.025

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.243

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.162

EMB10-20 ug/mL EthambutolcellWall

-0.327

Eta12-40 ug/mL EthionamidecellWall

-0.636

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.242

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.874

BZA0.12 mg/mL BenzamidearomaticAmides

-0.143

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.004

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.584

H2O24 mM hydrogen peroxideDNAdamaging

-0.768

Levo10 ug/mL LevofloxacinDNAdamaging

-0.211

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.490

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.039

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.527

Antimycin12.5-50 ug/mL Antimycin A?

-0.098

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.195

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.269

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.055

PA8240.2-2 ug/mL PA-824?

0.795

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.049

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

0.309

mercaptoethanol2 mM 2-Mercaptoethanol?

0.000

methoxatin10-20 ug/mL Methoxatin?